Bassani Medical currently operates a world class aeroponic SAPHRA licensed facility in Johannesburg, South Africa. As a premier cultivator of medical cannabis, it is our focus to supply global pharmaceutical markets with the highest quality product under European standards
We foster the very best practices in yielding, processing and proliferating pharmaceutical grade cannabis products of the highest quality. This commitment is our contribution to the growing global market of medical-use cannabis.
Cannabis products come in a variety of forms. At Bassani Medical, our products include flower, biomass, and API extracts.
Cannabis flower refers to the part of the plant that contains the highest concentration of cannabinoids, such as THC and CBD. It is typically consumed by smoking, vaporizing, or using it to make edibles or infused products.
Cannabis biomass refers to the leaves, stems, and other parts of the plant that are not used as flower. While not as potent as flower, biomass still contains significant amounts of cannabinoids and can be processed into other forms of cannabis products, such as extracts or edibles.
Cannabis API extracts are highly purified and standardized cannabinoid compounds extracted from the cannabis plant. These extracts can be used to produce pharmaceutical products such as pills, capsules, sprays, and inhalers that are designed to treat specific medical conditions.
Cannabis products come in a variety of forms. At Bassani Medical, our products include flower, biomass, and API extracts.
Cannabis flower refers to the part of the plant that contains the highest concentration of cannabinoids, such as THC and CBD. It is typically consumed by smoking, vaporizing, or using it to make edibles or infused products.
Cannabis biomass refers to the leaves, stems, and other parts of the plant that are not used as flower. While not as potent as flower, biomass still contains significant amounts of cannabinoids and can be processed into other forms of cannabis products, such as extracts or edibles.
Cannabis API extracts are highly purified and standardized cannabinoid compounds extracted from the cannabis plant. These extracts can be used to produce pharmaceutical products such as pills, capsules, sprays, and inhalers that are designed to treat specific medical conditions.
At Bassani Medical, we use the Aeroponics growing method. It allows us to use less energy, water and floor space while producing high quality cannabis combined with our pharmaceutical grade facility, cGMP trained staff, and world-class equipment. Aeroponic growing systems are like hydroponic techniques as they both supply nutrient formulas directly to exposed root systems.
Aeroponic systems are known for the quality product they produce and is sought after by the pharmaceutical market. The combination of growing indoors and applying nutrients directly to the roots allows for the development of large, healthy buds. We as growers also have a significant level of control over the quality, especially with regards to contaminants like heavy metals and microbiological growth contaminants. Aeroponics provide a sustainable and contaminant free pharmaceutical grade cannabis flower as a starting material for the pharmaceutical industry.
• Bassani Medical is one of only a few facilities in South Africa that have been granted a licence by SAPHRA to cultivate medical cannabis .
• Bassani Medical has exclusive agreements in place to supply its medical cannabis globally to Israel, Poland, United Kingdom and Germany. The estimated value of these sales alone over a year is conservatively more than R200 million and Bassani Medical is continuously engaging in negotiations to secure new deals.
• Bassani Medical’s cannabis is world class medical grade standard.
• The investment is secured by a bond over a property, providing real security for your investment.
• A competitive Return on Investment of between 10% and 12.5% per annum offers attractive potential earnings.
• The capital invested will be repaid within 10 years, ensuring a defined exit strategy for investors.
• The investment risk level is considered low, providing peace of mind for investors.
This investment opportunity offers NFT (Non-Fungible Token) holders a unique proposition where each NFT holder becomes a partner in a limited partnership.
As a limited partner, you would not be directly involved in the day-to-day management of the company’s operations, but you will benefit from the gains it makes. You would be a silent partner, whilst the general partner, Futurity actively manages the partnership.
The best part is that you have no liability. You simply buy an NFT and sit back and enjoy the returns on your investment.
This is a good way to structure private equity because it allows you to invest as part of a collective, and for you to enjoy rewards without exposing yourself to personal liability.
Bassani Medical’s business model is sound and promising, with off-take agreements to supply medical cannabis globally. This means Bassani Medical has already secured contracts with buyers who have committed to purchasing their medical cannabis products globally. The value of these agreements over less than a year is more than R200 million, which guarantees the returns on investment.
Further, Bassani Medical Bassani Medical is one of only a few facilities in South Africa that have been granted a licence by SAPHRA to cultivate medical cannabis, and Bassani Medical’s cannabis is world class medical grade standard.
Your investment secured by a bond over a property providing real security for your investment.
The minimum buy-in for investors is low.
A competitive Return on Investment of between 10% and 12.5% per annum offers attractive potential earnings.
The capital invested will be repaid within 10 years, ensuring a defined exit strategy for investors and providing investors with a predictable timeline for their returns.
The investment risk level is considered low, providing peace of mind for investors and making it an attractive opportunity for those seeking stable and secure investments.
For NFT holders seeking to diversify their portfolio and participate in a secure and lucrative opportunity, this deal holds strong potential for long-term financial growth.
What are the benefits of investing in an asset that is tokenised?
Tokenization in private equity refers to the process of converting ownership rights or assets into digital tokens on a blockchain. When applied to non-fungible tokens (NFTs), it allows for unique representation of assets, enabling fractional ownership and ease of transfer. The benefits of tokenization in private equity for the holder of an NFT include:
• Democratised Ownership: Tokenisation democratises private equity by making traditionally exclusive opportunities more accessible to a broader range of investors which promotes financial inclusion.
• Liquidity: NFT holders can trade or sell their private equity, thereby providing liquidity to traditionally illiquid assets.
• Transparency and Security: The blockchain technology behind NFTs provides a transparent and immutable record of ownership, enabling easy verification and reducing the risk of fraudulent activities. This transparency builds trust among investors and can lead to increased investment in private equity.
• Lower Barrier to Entry: By tokenizing private equity assets, the minimum investment threshold can be significantly lowered. This allows smaller investors to participate in ventures that were previously reserved for high-net-worth individuals or institutions.
• Faster Settlement: The use of blockchain technology enables faster and more efficient settlement of transactions, reducing the time it takes to complete a private equity deal and allowing investors to access their funds more quickly.
• Global Accessibility: NFTs and blockchain technology operate on a global scale without being bound by traditional financial systems. This opens up private equity investment opportunities to investors from different countries, fostering cross-border investments.
• Programmable Assets: Smart contracts associated with NFTs can automate certain aspects of the investment process, such as revenue sharing, profit distribution, or compliance requirements. This reduces administrative overhead and enhances efficiency.
• Diversification Opportunities: Tokenization allows investors to diversify their portfolio across a wider range of assets, including those that were not previously available through traditional investment channels.
As a premier cultivator of medical cannabis, it is our focus to supply global pharmaceutical markets with the highest quality product under European standards.
We foster the very best practices in yielding, processing and proliferating pharmaceutical grade cannabis products of the highest quality.
We operate in accordance with strict Good Agricultural and Collection Practices (GACP) and comply with current Good Manufacturing Practices (cGMP) as guided by the International Council for Harmonisation (ICH Q7).
We foster the very best practices in yielding, processing and proliferating pharmaceutical grade cannabis products of the highest quality. This commitment is our contribution to the growing global market of medical-use cannabis.
Bassani Medical is founded on core values that demonstrate trust, honesty, consistency, and responsibility. We know that deriving the cannabis plant with the utmost integrity can only enhance the role of cannabis in the future of health and wellbeing.
Bassani Medical’s brand values are shaped by attitudes and processes that closely reflect the values of our clients and partners in the pharmaceutical cannabis sector. We demonstrate respect for our employees, clients, shareholders, and the environment in which we operate.
Michael is an innovative and accomplished pharmaceutical executive and is renowned for uncovering opportunities that inspire aggressive growth. His 26 years in the industry includes lead executive portfolios such as the CEO and MD of Fine Chemicals Corporation, among others. He also enjoyed a successful stint managing his own business interests.
International exposure in the USA, Europe and China has given Michael a firm grasp of global and industry nuances, with experience in sales, manufacturing, laboratory, supply chain management, quality management, and strategic business management.
Michael has an MBA from the University of Cumbria (Wales, UK), has completed an Executive Leadership Programme (University of Cape Town) and Harvard Business School’s Leadership Development programme.
Michael brings the essential API experience, regulatory, technical expertise, and business development knowledge to Bassani Medical.
Tylo holds a Bachelors degree in Chemical Engineering from the Cape Peninsula University of Technology. Having served as a quality assurance inspector at Fine Chemicals Corporation, Tylo obtained his qualification as an ISO 9001 Internal & Suppliers Auditor. He is trained to ensure that cGMP is always adhered to in the production facility, including all quality and current good manufacturing practices (cGMP) requirements as outlined by company policies and procedures.
Tylo’s experience in keeping quality/cGMP records and reports timeously and accurately gives him the skills to manage and maintain all aspects of production equipment in the production facility, to achieve optimal yields and quality standards.
Johann is a highly astute, qualified and multi skilled Pharmaceutical Industry Management Professional with a versatile career spanning of 8 years. Johann has worked in various industry roles having started out as a Holiday Student Worker and Pharmacist Intern respectively. He excelled in the roles and grew along industry ranks becoming a Pharmacist in Charge, Pharmacist, Quality Assurance Pharmacist, Quality Assurance Manager and Responsible Pharmacist.
He holds MBA, M.Sc Pharmaceutical Chemistry (cum Laude) and B.Pharm (cum laude).
Shaakir holds a post graduate BSc-Agriculture honours degree from the University of KwaZulu-Natal majoring in horticultural plant Science. His thesis topic focused on Physiological & Morphological responses of Cannabis sativa to fertilizer dosages.
Shaakir obtained merit awards for Plant Production, Plant Breeding & Genetics, Forage production & utilization, Agricultural economics, Ag-Plant Physiology.
Skilled in the scientific and practical methodologies of optimising plant production.
Shaakir has insight into all stages of commercial plant production with in-depth understanding of plant biology, plant genetics, post-harvest physiology and management, as well as basic agricultural economics.
Ragini has over 20 years’ experience and obtained qualifications in Administration, Project Management and Business Management.
She has worked extensively with senior management teams in the quantity surveying, architectural, mining and construction environments. She works independently with skills that include critical thinking, problem solving and decision making.
SCHINDLERS DIGITAL ASSETS (PTY) LTD IS THE OWNER OF SCHINDLERSX AND IS A REGISTERED LICENSED FINANCIAL SERVICE PROVIDER, REGISTRATION NUMBER 53789
